Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akouos, Inc. - Common Stock (NQ: AKUS )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Akouos, Inc. - Common Stock

< Previous 1 2 Next >
Around $375 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed mixed on Thursday, there were a few notable insider trades. 
Via Benzinga
Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday. 
Via Benzinga
Carnival, Amazon, Iamgold And Other Big Gainers From Tuesday
U.S. stocks closed higher on Monday, with the Dow Jones gaining more than 300 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Is Akouos (AKUS) Stock Up 85% Today?
As a pharmaceutical giant seeks to delve deeper into gene therapy, today's merger announcement has AKUS stock traders in a frenzy. 
Via InvestorPlace
Why Akouos Stock Is on Fire Today
A buyout agreement is lighting a fire underneath the biotech's shares today. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
Upgrades 
Via Benzinga
FDA Clears Akouos' Gene Therapy Trial For Genetic Form Of Hearing Loss
Via Benzinga
AKOUOS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akouos, Inc. - AKUS
From Kahn Swick & Foti, LLC
Via Business Wire
Crude Oil Drops Over 2%; Akouos Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 300 points on Tuesday. 
Via Benzinga
Wall Street Extends Lead After Strong Earnings
Wall Street is building on yesterday's rally, with the Dow Jones Industrial Average boasting a more than 200-point lead after an impressive round of bank earnings. 
Via Talk Markets
Nasdaq Rises Over 100 Points; Goldman Sachs Tops Q3 Views
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Tuesday. 
Via Benzinga
Akouos: Q2 Earnings Insights
  Akouos (NASDAQ:AKUS) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Akouos (NASDAQ: AKUS) Enters Into Agreement to be Acquired by Eli Lilly (NYSE: LLY) at Valuation Up to $610 Million
Akouos, Inc. (NASDAQ: AKUS) is engaged as a precision genetic medicine company, which is focused on the research and development 
Via Spotlight Growth
Exposures Product Safety
Zovio (ZVO) Stock Soars 90% Ahead of Oct. 25 Dissolution Vote
Zovio (ZVO) stock is rocketing higher on Tuesday as investors prepare for an incredibly important vote next week! 
Via InvestorPlace
Health Care Company Eli Lilly Announces Acquisition of Akouos
Eli Lilly (NYSE:LLY) has announced an acquisition of Akouos (NASDAQ:AKUS) that is expected to be completed in Q4 of 2022. 
Via Benzinga
US Stocks Extend Monday's Gains; Dow Jumps Over 500 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining over 500 points on Tuesday. The Dow also climbed around 550 points on Monday. 
Via Benzinga
Eli Lilly Acquires Akouos For Over $450M To Accelerate Hearing Loss Gene Therapies
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Akouos (NASDAQ:AKUS) shares moved upwards by 86.2% to $13.05 during Tuesday's pre-market session. The company's market cap stands at $481.5 million. 
Via Benzinga
AKUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akouos, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
AVEO Pharmaceuticals, Akouos And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
Upgrades 
Via Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
Via Benzinga
Stocks Remain Shaky Midweek, Dow Sporting Muted Gains
As the first half of 2022 draws to an end, stocks continue to struggle for direction. 
Via Talk Markets
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
Via Benzinga
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month. 
Via Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday. 
Via Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.